To all:
Tuesday September 7, 7:00 am Eastern Time
Company Press Release
SOURCE: Affymetrix, Inc.
Affymetrix Commences Commercial Shipments of GeneChip(R)
Products From West Sacramento Manufacturing Facility
SANTA CLARA, Calif., Sept. 7 /PRNewswire/ -- Affymetrix, Inc. (Nasdaq: AFFX - news), today announced the first commercial shipment of
GeneChip® probe arrays from its newest manufacturing facility in West Sacramento, California. This facility will expand current manufacturing capabilities for Affymetrix' GeneChip technology to meet growing customer demand.
''We are pleased with the Company's progress in completing the validation and beginning the scale up of our new manufacturing operations in Sacramento. Sacramento is our first facility that was designed and built from the ground up expressly for the efficient manufacture of GeneChip probe arrays. Over time, we intend to produce the majority of our new and existing products at this facility, while our Sunnyvale site transitions its focus to product and process development,'' said Ronald D. Verdoorn, Executive Vice President of Worldwide Manufacturing Operations at Affymetrix. ''We
look forward to increasing our capacity at this location by adding more equipment and building out the unimproved portions of this facility to meet the increasing demands for Affymetrix' GeneChip arrays.''
The portion of the West Sacramento manufacturing facility that commenced commercial operations occupies approximately 35,000 square feet of manufacturing operations and office space. Plans are currently being evaluated to further expand capacity at this facility.
Affymetrix has developed and intends to establish its GeneChip system as the platform of choice for acquiring, analyzing and managing complex genetic information in order to improve the diagnosis, monitoring and treatment of disease. The Company's GeneChip system consists of disposable DNA probe arrays containing gene sequences on a chip, reagents for use with the probe arrays, a scanner and other instruments to process the probe arrays, and software to analyze and manage genetic information.
All statements in this press release that are not historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange
Act, including statements regarding the Company's ''expectations,'' ''beliefs,'' ''hopes,'' ''intentions,'' ''strategies'' or the like. Such statements are
subject to risks and uncertainties that could cause actual results to differ materially for Affymetrix from those projected, including, but not limited to,
uncertainties relating to technological approaches, product development, manufacturing, and market acceptance, uncertainties related to cost and pricing
of Affymetrix products, dependence on collaborative partners, uncertainties relating to sole source suppliers, uncertainties relating to FDA and other
regulatory approvals, competition, risks relating to intellectual property of others and the uncertainties of patent protection and litigation. These and other
risk factors are discussed in Affymetrix' Annual Report on Form 10-K for the year ended December 31, 1998 and 10-Q for the quarter ended June 30,
1999 and Form S-3 filed July 12, 1999, as amended. Affymetrix expressly disclaims any obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein to reflect any change in Affymetrix' expectations with regard thereto or any change in
events, conditions, or circumstances on which any such statements are based. Affymetrix, GeneChip and the Affymetrix logo are registered trademarks
used by Affymetrix, Inc.
SOURCE: Affymetrix, Inc.
This statement continues to be emphasised in the companies press releases:
"Affymetrix has developed and intends to establish its GeneChip system as the platform of choice for acquiring, analyzing and managing complex genetic information in order to improve the diagnosis, monitoring and treatment of disease."
This appears to bite off quite a bit IMO... the company is not just selling chips, but a proprietary hardware system and proprietary IT software as well and trying to establish the whole platform as the industry standard around which all others must dance... can anyone help me get a handle on how this fit's in with INCY's plan... ie. does anyone use BOTH services? Can you use both product lines together or are all customers with either one or the other?? Going to look into this when I get a chance, anyone else have a clue?
DAK |
